Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).

[1]  A. Fauci,et al.  Pulmonary Involvement in the Collagen Vascular Diseases1,2 , 2015 .

[2]  G. Raghu,et al.  Rheumatoid arthritis-interstitial lung disease-associated mortality. , 2011, American journal of respiratory and critical care medicine.

[3]  T. E. King,et al.  Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease , 2009, European Respiratory Journal.

[4]  T. Colby,et al.  Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. , 2009, Chest.

[5]  A. Nicholson,et al.  Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. , 2007, American journal of respiratory and critical care medicine.

[6]  K. Winthrop.  Serious infections with antirheumatic therapy: are biologicals worse? , 2006, Annals of the rheumatic diseases.

[7]  C. Kelly,et al.  Interstitial lung disease in patients with rheumatoid arthritis: comparison with cryptogenic fibrosing alveolitis over 5 years. , 2006, The Journal of rheumatology.

[8]  Frederick Wolfe,et al.  Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. , 2006, Arthritis and rheumatism.

[9]  F. Wolfe.  Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia : associations with prednisone, disease-modifying antirheumatic drugs, and antitumor necrosis factor therapy , 2006 .

[10]  J. Seo,et al.  Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. , 2005, Chest.

[11]  S. Gabriel,et al.  Cardiovascular death in rheumatoid arthritis: a population-based study. , 2005, Arthritis and rheumatism.

[12]  P. Laippala,et al.  Death rates and causes of death in patients with rheumatoid arthritis: a population‐based study , 2004, Scandinavian journal of rheumatology.

[13]  D. Curran‐Everett,et al.  The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. , 2004, The American journal of medicine.

[14]  C. Turesson,et al.  Management of extra-articular disease manifestations in rheumatoid arthritis , 2004, Current opinion in rheumatology.

[15]  C. Turesson,et al.  Epidemiology of extra‐articular manifestations in rheumatoid arthritis , 2004, Scandinavian journal of rheumatology.

[16]  J. Rasker,et al.  Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality. , 2004, The Journal of rheumatology. Supplement.

[17]  S. Gabriel,et al.  Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years , 2003, Annals of the rheumatic diseases.

[18]  F. Martinez,et al.  Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. , 2003, American journal of respiratory and critical care medicine.

[19]  S. Gabriel,et al.  Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. , 2003, Arthritis and rheumatism.

[20]  R. Hubbard,et al.  The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis. , 2002, Rheumatology.

[21]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[22]  S. Gabriel,et al.  Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. , 2002, The Journal of rheumatology.

[23]  B. Rajasekaran,et al.  Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic fibrosing alveolitis. , 2001, Rheumatology.

[24]  B. Gochuico.  Potential Pathogenesis and Clinical Aspects of Pulmonary Fibrosis Associated with Rheumatoid Arthritis , 2001, The American journal of the medical sciences.

[25]  A. Nicholson,et al.  The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. , 2000, American journal of respiratory and critical care medicine.

[26]  W. Travis,et al.  Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. , 2000, The American journal of surgical pathology.

[27]  L. Tanoue.  Pulmonary manifestations of rheumatoid arthritis. , 1998, Clinics in chest medicine.

[28]  D. Schwartz,et al.  Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. , 1996, Arthritis and rheumatism.

[29]  M. Obana,et al.  Cause of death in 81 autopsied patients with rheumatoid arthritis. , 1994, The Journal of rheumatology.

[30]  G. Hunninghake,et al.  Pulmonary manifestations associated with rheumatoid arthritis. , 1991, Chest.

[31]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[32]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[33]  M. Hakala,et al.  Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. , 1988, Chest.

[34]  R. Rothenberg,et al.  Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy. , 1987, Seminars in arthritis and rheumatism.

[35]  C. Carrington,et al.  Lung biopsy in rheumatoid arthritis. , 1985, The American review of respiratory disease.

[36]  B. Burrows,et al.  Cryptogenic fibrosing alveolitis: clinical features and their influence on survival , 1980, Thorax.

[37]  A. Fauci,et al.  Pulmonary involvement in the collagen vascular diseases. , 1979, The American review of respiratory disease.

[38]  J. Talbott,et al.  PULMONARY INVOLVEMENT IN RHEUMATOID ARTHRITIS. , 1964, JAMA.

[39]  P. Ellman,et al.  “Rheumatoid Disease” with Joint and Pulmonary Manifestations , 1948, British medical journal.